Skip to main content
Year archive

TRIVARX LTD — 2018 filings

All 81 regulatory filings released by TRIVARX LTD (TRI) in 2018, sourced directly from the official regulator.

81 Filings
2018 Period
2018 filings (81)
Filing Released Lang
Medibio announces board changes and cost reduction plans 2 pages 220.1KB
Regulatory Filings
2018-12-23 English
Notice of General Meeting/Proxy Form 12 pages 606.0KB
Regulatory Filings
2018-12-20 English
Cleansing Notice and Appendix 3B 27 pages 801.0KB
Regulatory Filings
2018-12-17 English
Entitlement Offer Booklet 30 pages 1.1MB
Regulatory Filings
2018-12-17 English
Letter to Shareholders - Entitlement Offer 3 pages 137.3KB
Regulatory Filings
2018-12-10 English
Letter to Ineligible Shareholders - Entitlement Offer 2 pages 135.6KB
Regulatory Filings
2018-12-10 English
Converting Note & Non-Renounceable Entitlement Offer 3 pages 62.6KB
Regulatory Filings
2018-12-09 English
Investor Presentation 35 pages 3.7MB
Regulatory Filings
2018-12-09 English
Section 708AA(2)(F) Cleansing Statement and Appendix 3B 14 pages 268.2KB
Regulatory Filings
2018-12-09 English
Notification of Pro-Rata Non-Renounceable Entitlement Issue 1
Regulatory Filings
2018-12-09 English
Pause in Trading 1 page 111.4KB
Regulatory Filings
2018-12-05 English
Trading Halt 2 pages 411.5KB
Regulatory Filings
2018-12-05 English
Investor Presentation 30 pages 3.6MB
Regulatory Filings
2018-11-27 English
Exclusive Agreement Signed for ilumen Pilot Program 2 pages 232.5KB
Regulatory Filings
2018-11-26 English
Chairman's Address to Shareholders 2 pages 114.8KB
Regulatory Filings
2018-11-15 English
Results of Annual General Meeting 2 pages 120.2KB
Regulatory Filings
2018-11-15 English
Appointment of Joint Company Secretary 1 page 185.0
Regulatory Filings
2018-11-15 English
Response to ASX Appendix 4C Query 4 pages 562.5KB
Regulatory Filings
2018-11-14 English
Change of Director's Interest Notice 2 pages 248.6KB
Regulatory Filings
2018-11-13 English
Medibio Provides Update on FDA Process 2 pages 189.9KB
Regulatory Filings
2018-11-08 English
Initial Director's Interest Notice 2 pages 178.8KB
Regulatory Filings
2018-11-07 English
Change of Director's Interest Notice x2 4 pages 196.8KB
Regulatory Filings
2018-11-07 English
Medibio Market Update 1 page 169.8KB
Regulatory Filings
2018-11-01 English
Medibio Appoints CEO and Managing Director 3 pages 211.8KB
Regulatory Filings
2018-11-01 English
Medibio Quarterly Update and Cashflow Report 12 pages 359.7KB
Regulatory Filings
2018-10-29 English
MEB Signs ilumen Contract with Large Australian Employer 2 pages 213.5KB
Regulatory Filings
2018-10-23 English
Notice of Annual General Meeting/Proxy Form 30 pages 6.0MB
Regulatory Filings
2018-10-15 English
Receipt of R&D Tax Incentive Refund 1 page 96.0KB
Regulatory Filings
2018-10-14 English
MEB Presentations - Mayo Clinic Convergence Neuroscience 2 pages 99.1KB
Regulatory Filings
2018-10-07 English
Investor Presentation 21 pages 11.4MB
Regulatory Filings
2018-10-04 English
Medibio Releases Corporate Health Product, ilumen 2 pages 178.2KB
Regulatory Filings
2018-10-02 English
Notice of Initial Substantial Holder 5 pages 1.7MB
Regulatory Filings
2018-10-01 English
Notice Received Under Section 249D of the Corporations Act 1
Regulatory Filings
2018-09-30 English
Annual Report to shareholders 84 pages 6.0MB
Regulatory Filings
2018-09-26 English
Executive Leadership Changes 2 pages 106.8KB
Regulatory Filings
2018-09-20 English
Final Director's Interest Notice 2 pages 188.2KB
Regulatory Filings
2018-09-20 English
Annual Report to shareholders 71 pages 1.8MB
Regulatory Filings
2018-09-13 English
Appendix 4G & Corporate Governance Statement 20 pages 417.2KB
Regulatory Filings
2018-09-13 English
Medibio Market Update 4 pages 208.3KB
Regulatory Filings
2018-09-09 English
Medibio Hosts Call to Discuss Clinical Validation Study 2 pages 168.6KB
Regulatory Filings
2018-09-06 English
Clinical Study Shows Improvement to Diagnostic Standard 3 pages 272.7KB
Regulatory Filings
2018-09-05 English
Preliminary Final Report 40 pages 693.9KB
Regulatory Filings
2018-08-29 English
Departure of Managing Director & Chief Executive Officer 1
Regulatory Filings
2018-08-28 English
Pause in Trading 1 page 111.7KB
Regulatory Filings
2018-08-27 English
Trading Halt 2 pages 353.8KB
Regulatory Filings
2018-08-27 English
MEB to announce fourth quarter FY18 results (Updated) 2 pages 128.9KB
Regulatory Filings
2018-07-30 English
Medibio Quarterly Update and Cashflow Report 12 pages 316.8KB
Regulatory Filings
2018-07-30 English
MEB to announce fourth quarter FY18 results 2 pages 128.8KB
Regulatory Filings
2018-07-29 English
Medibio Submits FDA De Novo Application 2 pages 104.2KB
Regulatory Filings
2018-07-15 English
Medibio Science published in EC Neurology 1 page 17
Regulatory Filings
2018-06-26 English
Appendix 3B 13 pages 218.1KB
Regulatory Filings
2018-06-20 English
Change of Director's Interest Notices x6 12 pages 291.4KB
Regulatory Filings
2018-06-20 English
Medibio Receives TGA Approval 1 page 135.9KB
Regulatory Filings
2018-06-18 English
Medibio to provide Corporate Health Investor Presentation 24 pages 8.4MB
Regulatory Filings
2018-06-17 English
Medibio provides updated Investor Presentation 34 pages 14.3MB
Regulatory Filings
2018-06-11 English
Results of Meeting 2 pages 235.6KB
Regulatory Filings
2018-06-05 English
Company Secretary Appointment/Resignation 1 page 96
Regulatory Filings
2018-06-05 English
MEB Signs Global Contract with Jacobs Engineering 2 pages 201.4KB
Regulatory Filings
2018-05-24 English
Medibio Announces Next Tranche of Corporate Health Contracts 2 pages 157.7KB
Regulatory Filings
2018-05-09 English
Medibio Signs First Corporate Health Contract 2 pages 159.3KB
Regulatory Filings
2018-05-08 English
Notice of Extraordinary General Meeting/Proxy Form 26 pages 513.3KB
Regulatory Filings
2018-05-06 English
Medibio Receives CE Certification 2 pages 151.6KB
Regulatory Filings
2018-05-02 English
Medibio Announces Global Corporate Mental Health Launch 3 pages 187.9KB
Regulatory Filings
2018-04-30 English
Medibio Quarterly Update and Cashflow Report 12 pages 582.7KB
Regulatory Filings
2018-04-29 English
MEB to announce third quarter FY18 update and cashflow 2 pages 217.3KB
Regulatory Filings
2018-04-26 English
Medibio Announces Scientific Advisory Board 4 pages 140.4KB
Regulatory Filings
2018-04-25 English
Appendix 3B & S708 cleansing notice 14 pages 219.1KB
Regulatory Filings
2018-04-16 English
Medibio completes Vital Conversation acquisition 2 pages 203.7KB
Regulatory Filings
2018-04-11 English
Change in substantial holding 3 pages 200.6KB
Regulatory Filings
2018-04-10 English
Investor Update 23 pages 7.3MB
Regulatory Filings
2018-03-04 English
MEB signs binding term sheet to acquire Vital Conversations 2 pages 173.6KB
Regulatory Filings
2018-03-04 English
Appendix 3B and S708 cleansing statement 15 pages 212.2KB
Regulatory Filings
2018-03-04 English
Half Yearly Report and Accounts 26 pages 824.7KB
Regulatory Filings
2018-02-26 English
Medibio Quarterly Update and Cash Flow Report 12 pages 203.8KB
Regulatory Filings
2018-01-30 English
MEB to announce second quarter FY18 update and cashflow 1
Regulatory Filings
2018-01-29 English
Peter Carlisle Appointed as Director 2 pages 139.5KB
Regulatory Filings
2018-01-21 English
Agreement with Striiv to Accelerate Commercialisation 2 pages 126.9KB
Regulatory Filings
2018-01-21 English
Final Director's Interest Notice 2 pages 87.6KB
Regulatory Filings
2018-01-21 English
Resignation of Director 1 page 80.8KB
Regulatory Filings
2018-01-18 English
Appendix 3B 13 pages 171.2KB
Regulatory Filings
2018-01-15 English
Medibio Announces ISO 13485 Certification 1 page 17
Regulatory Filings
2018-01-09 English